CX3CL1 and viral infectious disease: Thus, the CX3C motif might compete with fractalkine for CX3CR1 binding (Chirkova et al., 2013) and subsequently disrupt the fractalkine-induced Th1-polarized response, which is beneficial for the body to rule out viral infection.